Fredun Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Fredun Pharmaceuticals Ltd. on BSE

Load latest

Fredun Pharmaceuticals Ltd.

31 May 2025

1216.75

-0.98%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Revised Outcome Of The Board Meeting Dated 30.05.2025

BSE India

Revised Outcome of the Board Meeting dated 30.05.2025

pdf

Fredun Pharmaceuticals Ltd.

31 May 2025

1216.75

-0.98%

Result

Fredun Pharmaceuticals Ltd - 539730 - Standalone And Consolidated Audited Financial Results For The Quarter And …

BSE India

Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2025 along with Statement of Assets and Liabilities and Cash Flow Statement

pdf

Fredun Pharmaceuticals Ltd.

31 May 2025

1216.75

-0.98%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release of Fredun Pharmaceuticals for Q4 and FY25 Robust Performance.

pdf

Fredun Pharmaceuticals Ltd.

31 May 2025

1216.75

-0.98%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation of re-appointment of Secretarial Auditor, Internal Auditor and Cost Auditor.

pdf

Fredun Pharmaceuticals Ltd.

31 May 2025

1216.75

-0.98%

Result

Fredun Pharmaceuticals Ltd - 539730 - Standalone And Consolidated Financial Results For The Period Ended On …

BSE India

Standalone and Consolidated Financial results for the period ended on 31st March 2025.

pdf

Fredun Pharmaceuticals Ltd.

31 May 2025

1216.75

-0.98%

Board Meeting

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

To consider approve and adopt The Standalone and consolidated Audited Financial Results for the Quarter and Financial year ended March, 31 2025

pdf

Fredun Pharmaceuticals Ltd.

30 May 2025

1216.75

-0.98%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for the FY year ended 31st March, 2025.

pdf

Fredun Pharmaceuticals Ltd.

22 May 2025, 04:39PM

1216.75

-0.98%

Board Meeting

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Prior Intimation For The Board Meeting …

BSE India

Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Friday, 30th May, 2025 inter alia, to consider and approve the following: 1. Consider and approve Audited Financial Results & Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March, 2025. 2. Consider and recommend final dividend on the paid-up equity shares for the Financial Year ended 31st March, 2025. Further, as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in Securities of the Company shall remain closed until the expiry of 48 hours after the declaration of the said Financial Results.

pdf